Molecule created in Brazil helps fight heart failure

A molecule designed at the Institute of Biomedical Sciences of the University of São Paulo (ICB-USB) may increase the quality of life and life expectancy of people suffering from congestive heart failure.

Pharmacy. Image credit: MarkBuckawicki/Wikimedia Commons (CC0)

The new molecule—built by ICB in cooperation with the University of Stanford, in the US—paves the way for new medications capable of checking the evolution of the disease more efficiently than the ones available today.

Heart failure is the last stage of a number of cardiovascular diseases—the world’s most fatal disorders.

“Most medications available today for the treatment of heart failure were developed in the 1980s and have their effect outside of the heart cell. We need more effective medicines controlling the critical processes in the affected heart cell, capable of increasing the patient’s lifetime and quality of life. But it’s an arduous task,” said ICB professor and study coordinator Julio Cesar Batista Ferreira.

According to the ICB, the treatment with the synthesized molecule, dubbed Samba, stopped the evolution of heart failure in animals. Mice with heart failure that were treated for six weeks with the molecule showed not only that the disease had been stabilized—as usual with present-day medications—but also the improvement in condition. The specimens presented better capacity to contract their heart muscle.

The molecule was also tested on human heart cells. Results showed that, in addition to checking the deterioration of the disease, cells’ capacity to contract was seen to increase. “Current drugs stop the evolution of the disease, but never make it subside. What we have demonstrated is that, by regulating this particular interaction, the evolution is decreased, and it also brings the condition to a lighter state,” Ferreira said. (Agência Brasil)

YOU MAY ALSO LIKE

Eyes of CJD patients show evidence of prions

Scientists have found evidence of the infectious agent of sporadic Creutzfeldt-Jakob disease (CJD) in the eyes of deceased CJD patients. The finding suggests that the eye may be a source for early CJD diagnosis and raises questions about the safety of routine eye exams and corneal transplants.

Asteroid-Hunting Spacecraft Delivers a Second Year of Data

NASA's Near-Earth Object Wide-field Survey Explorer (NEOWISE) mission has released its second year of survey data. The spacecraft has now characterized a total of 439 NEOs since the mission was re-started in December 2013. Of these, 72 were new discoveries.

Methane-eating microorganisms help regulate emissions from wetlands

Though they occupy a small fraction of Earth's surface, freshwater wetlands are the largest natural source of methane emitted into the atmosphere. New research identifies an unexpected process that acts as a key gatekeeper in regulating methane emissions from these freshwater environments.

Fire control harms biodiversity in Brazilian savannah

Policies that prevent fires caused by people in El Cerrado (the Brazilian savannah) lead to biodiversity losses because they promote the expansion of forests with dense vegetation.

Novel Technology Uses Bacteria for Cleaning Water

A novel technology was developed by Indian-origin researchers that can clean water twice as fast as commercially available ultrafiltration membranes.

Elevated hormone flags liver problems in mice with methylmalonic acidemia

Researchers have discovered that a hormone, fibroblast growth factor 21, is extremely elevated in mice with liver disease that mimics the same condition in patients with methylmalonic acidemia, a serious genomic disorder.